The effect of lithium carbonate on leukopenia after chemotherapy

Paul S. Lietman, Peter G. Steinherz, Gerald Rosen, Fereshteh Ghavimi, Ying Wang, Denis R. Miller

Research output: Contribution to journalArticle

Abstract

Two evaluate the efficacy of lithium carbonate in ameliorating leukopenia, 37 patients (3 to 26 years old, median 15) with normal marrow elements, on chemotherapeutic regimens that produce leukopenia (≤1,000/mm3) over 40% of the time were designated at random on the last day of 82 separate chemotherapy courses to receive lithium or no treatment. Four could not take the drug because of the size of the capsules. There were 39 controls and 39 patients given lithium. Blood levels were maintained at 0.2 to 1.2 mEq/l (median 0.7). The median drop of WBC in the treated group was 3,400/mm3 with a nadir of 1,800/mm3 vs 5,000 and 1,400, respectively, for the untreated patients (P3) while 14 (36%) in the control group become leukopenic to that extent. Twenty-four patient days were spent with the WBC ≤1,000/mm3 after lithium and 57 days in the control group. Three patients required admission for 24 hospital days for fever while leukopenic after lithium, whereas seven patients spent 62 days in the hospital in the control group. Lithium reduces the period of leukopenia after chemotherapy during which time the patients may acquire infections.

Original languageEnglish (US)
Pages (from-to)923-927
Number of pages5
JournalJournal of Pediatrics
Volume96
Issue number5
DOIs
StatePublished - 1980
Externally publishedYes

Fingerprint

Lithium Carbonate
Leukopenia
Lithium
Drug Therapy
Control Groups
Patient Admission
Capsules
Fever
Bone Marrow
Infection
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Lietman, P. S., Steinherz, P. G., Rosen, G., Ghavimi, F., Wang, Y., & Miller, D. R. (1980). The effect of lithium carbonate on leukopenia after chemotherapy. Journal of Pediatrics, 96(5), 923-927. https://doi.org/10.1016/S0022-3476(80)80583-X

The effect of lithium carbonate on leukopenia after chemotherapy. / Lietman, Paul S.; Steinherz, Peter G.; Rosen, Gerald; Ghavimi, Fereshteh; Wang, Ying; Miller, Denis R.

In: Journal of Pediatrics, Vol. 96, No. 5, 1980, p. 923-927.

Research output: Contribution to journalArticle

Lietman, PS, Steinherz, PG, Rosen, G, Ghavimi, F, Wang, Y & Miller, DR 1980, 'The effect of lithium carbonate on leukopenia after chemotherapy', Journal of Pediatrics, vol. 96, no. 5, pp. 923-927. https://doi.org/10.1016/S0022-3476(80)80583-X
Lietman PS, Steinherz PG, Rosen G, Ghavimi F, Wang Y, Miller DR. The effect of lithium carbonate on leukopenia after chemotherapy. Journal of Pediatrics. 1980;96(5):923-927. https://doi.org/10.1016/S0022-3476(80)80583-X
Lietman, Paul S. ; Steinherz, Peter G. ; Rosen, Gerald ; Ghavimi, Fereshteh ; Wang, Ying ; Miller, Denis R. / The effect of lithium carbonate on leukopenia after chemotherapy. In: Journal of Pediatrics. 1980 ; Vol. 96, No. 5. pp. 923-927.
@article{4d645b952e7746f49e759cf270bc1597,
title = "The effect of lithium carbonate on leukopenia after chemotherapy",
abstract = "Two evaluate the efficacy of lithium carbonate in ameliorating leukopenia, 37 patients (3 to 26 years old, median 15) with normal marrow elements, on chemotherapeutic regimens that produce leukopenia (≤1,000/mm3) over 40{\%} of the time were designated at random on the last day of 82 separate chemotherapy courses to receive lithium or no treatment. Four could not take the drug because of the size of the capsules. There were 39 controls and 39 patients given lithium. Blood levels were maintained at 0.2 to 1.2 mEq/l (median 0.7). The median drop of WBC in the treated group was 3,400/mm3 with a nadir of 1,800/mm3 vs 5,000 and 1,400, respectively, for the untreated patients (P3) while 14 (36{\%}) in the control group become leukopenic to that extent. Twenty-four patient days were spent with the WBC ≤1,000/mm3 after lithium and 57 days in the control group. Three patients required admission for 24 hospital days for fever while leukopenic after lithium, whereas seven patients spent 62 days in the hospital in the control group. Lithium reduces the period of leukopenia after chemotherapy during which time the patients may acquire infections.",
author = "Lietman, {Paul S.} and Steinherz, {Peter G.} and Gerald Rosen and Fereshteh Ghavimi and Ying Wang and Miller, {Denis R.}",
year = "1980",
doi = "10.1016/S0022-3476(80)80583-X",
language = "English (US)",
volume = "96",
pages = "923--927",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - The effect of lithium carbonate on leukopenia after chemotherapy

AU - Lietman, Paul S.

AU - Steinherz, Peter G.

AU - Rosen, Gerald

AU - Ghavimi, Fereshteh

AU - Wang, Ying

AU - Miller, Denis R.

PY - 1980

Y1 - 1980

N2 - Two evaluate the efficacy of lithium carbonate in ameliorating leukopenia, 37 patients (3 to 26 years old, median 15) with normal marrow elements, on chemotherapeutic regimens that produce leukopenia (≤1,000/mm3) over 40% of the time were designated at random on the last day of 82 separate chemotherapy courses to receive lithium or no treatment. Four could not take the drug because of the size of the capsules. There were 39 controls and 39 patients given lithium. Blood levels were maintained at 0.2 to 1.2 mEq/l (median 0.7). The median drop of WBC in the treated group was 3,400/mm3 with a nadir of 1,800/mm3 vs 5,000 and 1,400, respectively, for the untreated patients (P3) while 14 (36%) in the control group become leukopenic to that extent. Twenty-four patient days were spent with the WBC ≤1,000/mm3 after lithium and 57 days in the control group. Three patients required admission for 24 hospital days for fever while leukopenic after lithium, whereas seven patients spent 62 days in the hospital in the control group. Lithium reduces the period of leukopenia after chemotherapy during which time the patients may acquire infections.

AB - Two evaluate the efficacy of lithium carbonate in ameliorating leukopenia, 37 patients (3 to 26 years old, median 15) with normal marrow elements, on chemotherapeutic regimens that produce leukopenia (≤1,000/mm3) over 40% of the time were designated at random on the last day of 82 separate chemotherapy courses to receive lithium or no treatment. Four could not take the drug because of the size of the capsules. There were 39 controls and 39 patients given lithium. Blood levels were maintained at 0.2 to 1.2 mEq/l (median 0.7). The median drop of WBC in the treated group was 3,400/mm3 with a nadir of 1,800/mm3 vs 5,000 and 1,400, respectively, for the untreated patients (P3) while 14 (36%) in the control group become leukopenic to that extent. Twenty-four patient days were spent with the WBC ≤1,000/mm3 after lithium and 57 days in the control group. Three patients required admission for 24 hospital days for fever while leukopenic after lithium, whereas seven patients spent 62 days in the hospital in the control group. Lithium reduces the period of leukopenia after chemotherapy during which time the patients may acquire infections.

UR - http://www.scopus.com/inward/record.url?scp=0018857215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018857215&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(80)80583-X

DO - 10.1016/S0022-3476(80)80583-X

M3 - Article

C2 - 6767826

AN - SCOPUS:0018857215

VL - 96

SP - 923

EP - 927

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 5

ER -